Our Future Health in 2026: Access new data types and recruit participants for your research and clinical trials
Join this webinar delivered by Our Future Health - the UK's largest health research programme with a cohort of over 2.5 million consented participants - to discover how they can support your research and clinical trials.
Now available:
- Imputed data
- Geographic data
- Dispensed medication records
- Participant recruitment
Michael Cook
Michael Cook is the Executive Director of Science at Our Future Health, a UK-based not-for-profit organisation that aims to recruit 5 million UK-resident adults into a prospective cohort study. To date, 2.5 million participants have consented, 1.9 million have completed the baseline questionnaire, 1.7 million have been linked to electronic health records, and 1.5 million have completed an in-person appointment to donate health metrics and blood, making Our Future Health the largest prospective cohort study with biobanked blood samples in the world. Michael provides senior and broad expertise in the molecular and epidemiological sciences, and was previously a tenured, Senior Investigator at the US National Cancer Institute, NIH.
Kate Evans
Kate Evans is the Executive Director of Researcher Data and Product, Our Future Health. Kate’s role is to ensure that Our Future Health data enables researchers to do groundbreaking work. She also looks after the product function. Kate spent nearly 20 years in UK government national security, using data and technology to keep the country safe.
Dr Emma Lawrence
What does your role at BIA involve?
Emma leads BIA's genomics, digital, data and artificial intelligence (AI) policy areas. She engages with members who work in these fields to understand their policy needs. Emma provides the secretariat for BIA's Genomics Advisory Committee (GAC) and looks after the TechBio community as part of this. Emma also leads BIA's influence agenda for these areas, engaging with civil servants and other senior stakeholders.
Previous experience
Prior to joining the BIA, Emma worked at the cross-party think tank Policy Connect on a Cell and Gene Therapy Parliamentary engagement programme. She has previously worked in the biomedical research sector understanding the barriers to accessing human samples and data for research. This included leading engagement at the UKCRC Tissue Directory and Coordination Centre (UCL) and the Immunotherapy Trial Simulation Project (Imperial College London). Emma has a PhD in Immunology from the University of Manchester.
If you could invite any scientist or entrepreneur to dinner, who would it be and why?
Ada Lovelace, the godmother of computer programming because she was the first to recognise that a machine would have uses beyond calculations. We’d chat about maths and 19th-century gossip over cocktails.
BIA Annual Supporters
